Interplay of Impaired Cellular Bioenergetics and Autophagy in PMM2-CDG
نویسندگان
چکیده
Congenital disorders of glycosylation (CDG) and mitochondrial are multisystem with overlapping symptomatology. Pathogenic variants in the PMM2 gene lead to abnormal N-linked glycosylation. This disruption can induce endoplasmic reticulum stress, contributing disease pathology. Although impaired dysfunction has been reported some CDG, cellular bioenergetics never evaluated detail PMM2-CDG. prompted us evaluate function autophagy/mitophagy vitro patient-derived fibroblast lines differing genotypes from our natural history study. We found secondary was evidenced by decreased maximal ATP-linked respiration, as well complex I electron transport chain. Our study also revealed altered autophagy PMM2-CDG lines. marked an increased abundance autophagosome marker LC3-II. Additionally, changes proteins mitophagy pathways further indicated dysregulation these processes. Interestingly, serum sorbitol levels (a biomarker severity) CDG severity score showed inverse correlation suggests that may act a modulator biochemical clinical markers Overall, research sheds light on interplay between glycosylation, function, Manipulating alterations could offer therapeutic benefits when combined existing treatments for
منابع مشابه
A Clinical Case with Pmm2-cdg and Dandy-walker Malformation
M. Stancheva1, I. Kremenski2, M. Apostolova3 , J. Jaeken4, E. van Schaftingen5, G. Matthijs6, N. Ivanova3, V. Bojinova7, B. Radeva8, P. Perenovska1, K. Vladimirova2, R. Vajarova2 and D. Todorova7 1Department of Pediatrics, University Children`s Hospital “ Alexandrovska”, So a, Bulgaria 2National Genetic Laboratory, So a, Bulgaria 3Bulgarian Academy of Science, Laboratory for Medico-biological R...
متن کاملPhosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment
BACKGROUND Phosphomannomutase deficiency (PMM2-CDG) is the most frequent congenital disorder of glycosylation. The cerebellum is nearly always affected in PMM2-CDG patients, a cerebellar atrophy progression is observed, and cerebellar dysfunction is their main daily functional limitation. Different therapeutic agents are under development, and clinical evaluation of drug candidates will require...
متن کاملChild Neurology: a case of PMM2-CDG (CDG 1a) presenting with unusual eye movements.
Rohini Coorg, MD Timothy E. Lotze, MD Congenital disorders of glycosylation encompass a group of diseases resulting from abnormal protein glycosylation. This group includes more than 20 described diseases.1 PMM2-CDG, previously referred to as congenital disorder of glycosylation type 1a (CDG 1a), is the most common of the congenital disorders of glycosylation. PMM2-CDG is associated with autoso...
متن کاملThe Effects of PMM2-CDG-Causing Mutations on the Folding, Activity, and Stability of the PMM2 Protein.
Congenital disorder of glycosylation type Ia (PMM2-CDG), the most common form of CDG, is caused by mutations in the PMM2 gene that reduce phosphomannomutase 2 (PMM2) activity. No curative treatment is available. The present work describes the functional analysis of nine human PMM2 mutant proteins frequently found in PMM2-CDG patients and also two murine Pmm2 mutations carried by the unique PMM2...
متن کاملCellular bioenergetics is impaired in patients with chronic fatigue syndrome
Chronic fatigue syndrome (CFS) is a highly debilitating disease of unknown aetiology. Abnormalities in bioenergetic function have been cited as one possible cause for CFS. Preliminary studies were performed to investigate cellular bioenergetic abnormalities in CFS patients. A series of assays were conducted using peripheral blood mononuclear cells (PBMCs) from CFS patients and healthy controls....
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Genes
سال: 2023
ISSN: ['2073-4425']
DOI: https://doi.org/10.3390/genes14081585